Guideline Rating: Medium-High
- This consensus statement is useful for anyone considering genetic testing for genes affecting breast cancer. It is useful for previvors who have not had cancer but who may be at high risk, and for breast cancer survivors whose treatment options may be affected.
- This information has immediate clinical utility.
- This consensus statement is focused on genetic testing for hereditary breast cancer; as such it is directly applicable for breast cancer patients and previvors.
- This is a consensus from the American Society of Breast Surgeons (ASBS), a professional organization. It is not mandatory but it is a suggested set of statements about best practices.
- Parts of this statement reflect lack of consensus among health care providers about which genes to test, how to test them and what particular clinical choices should be made given particular test results.
- As a result, this is not practice-changing but rather a consolidation of the current understanding about genetic testing and the opinions of the ASBS review committee. It does not add new data about genetic testing.
Clinical Timeline: Post-approval
Post-Approval (i.e. currently applicable to patients with breast cancer or previvors seeking genetic testing)